# Inflammation in Primary and Secondary Malignancies of the Central Nervous System Using [C-11]-CS1P1

> **NCT07462507** · PHASE2 · RECRUITING · sponsor: **Washington University School of Medicine** · enrollment: 104 (estimated)

## Conditions studied

- Central Nervous System Cancer
- Brain Metastases

## Interventions

- **DRUG:** [C-11]-CS1P1
- **DEVICE:** Brain MRI

## Key facts

- **NCT ID:** NCT07462507
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-04-16
- **Primary completion:** 2031-06-30
- **Final completion:** 2033-06-30
- **Target enrollment:** 104 (ESTIMATED)
- **Last updated:** 2026-04-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07462507

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07462507, "Inflammation in Primary and Secondary Malignancies of the Central Nervous System Using [C-11]-CS1P1". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT07462507. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*